SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-003778
Filing Date
2018-01-24
Accepted
2018-01-24 16:03:36
Documents
4
Period of Report
2018-01-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-28312_48k.htm 8-K 29167
2 EX-1.1 a17-28312_4ex1d1.htm EX-1.1 614474
3 EX-5.1 a17-28312_4ex5d1.htm EX-5.1 16794
4 GRAPHIC g283124kii001.gif GRAPHIC 2263
  Complete submission text file 0001104659-18-003778.txt   664819
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35619 | Film No.: 18545201
SIC: 2834 Pharmaceutical Preparations